scholarly article | Q13442814 |
P356 | DOI | 10.4244/EIJY14M06_01 |
P698 | PubMed publication ID | 24929350 |
P50 | author | Mauricio G. Cohen | Q39066286 |
Jarosław Kasprzak | Q68692773 | ||
Jan H Cornel | Q91960546 | ||
Ian J. Sarembock | Q106705959 | ||
John H. Alexander | Q110877755 | ||
P2093 | author name string | Roxana Mehran | |
Richard C Becker | |||
Christopher E Buller | |||
Gilles Montalescot | |||
Thomas J Povsic | |||
John P Vavalle | |||
Peter S Fail | |||
Steven L Zelenkofske | |||
Laura H Aberle | |||
RADAR Investigators | |||
P433 | issue | 4 | |
P921 | main subject | anticoagulation | Q63279445 |
P304 | page(s) | 431-438 | |
P577 | publication date | 2014-08-01 | |
P1433 | published in | EuroIntervention | Q26842537 |
P1476 | title | Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study | |
P478 | volume | 10 |
Q38290290 | Aptamers as targeted therapeutics: current potential and challenges |
Q41901691 | High-affinity RNA Aptamers Against the HIV-1 Protease Inhibit Both In Vitro Protease Activity and Late Events of Viral Replication |
Q57174720 | RNA Therapeutics in Cardiovascular Precision Medicine |
Q36580126 | Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant |
Q89217812 | Venous thrombosis |
Search more.